MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-28-0011963
Bacfo Pharmaceuticals (India ) Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹76.93 Cr
▲ 24% YoY
Net profit · FY 2025
₹2.5 Cr
Net margin 3.2%
EBITDA · FY 2025
₹8 Cr
EBITDA margin 10.4%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹2.61 Cr
Issued & subscribed
Open charges
₹27.1 Cr
Satisfied ₹8.61 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
224
Provident fund records
About Bacfo Pharmaceuticals (India ) Limited
Data last updated:
Bacfo Pharmaceuticals (India ) Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 October 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PLC062272. Its GSTIN is 09AABCB0033E1ZD (Uttar Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹2.61 Cr. It is led by directors including Arun Chauhan (Managing Director) and Achal Kumar Chauhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 27 Defence Colony Ring Road Defence Colony, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.93 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹2.5 Cr (net margin 3.2%) and EBITDA of ₹8 Cr (EBITDA margin 10.4%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 39% over five years.
The company has about 224 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: BACFO Pharmaceuticals. As per MCA filings, the company has open charges of ₹27.1 Cr and satisfied charges of ₹8.61 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 2 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in March 2022. Its 3 peer companies in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Adroit Pharmaceuticals Private Limited with revenue of ₹80.51 Cr.
Bacfo Pharmaceuticals (India ) Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0011963). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bacfo.com.
Company details
CIN U74899DL1994PLC062272
Registration Number 062272
Incorporation Date 20 October 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UP-28-0011963
CIN history
Bacfo Pharmaceuticals (India ) has one previous CIN (Corporate Identification Number): L74899DL1994PLC062272. The current CIN is U74899DL1994PLC062272, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899DL1994PLC062272 | Current |
| L74899DL1994PLC062272 | Previous |
Recognitions & Rankings of Bacfo Pharmaceuticals (India )
Contact details
Bacfo Pharmaceuticals (India ) Limited's registered office is in New Delhi, Delhi. Its website is bacfo.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressE – 27 Defence Colony Ring Road Defence Colony, New Delhi, Delhi, India – 110024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Comprehensive company report
Bacfo Pharmaceuticals (India ) Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bacfo Pharmaceuticals (India ) operates one associated brand: BACFO Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of nutraceutical supplements, herbal medicines, and personal care products. | bacfo.com |
Business activity
The main business activity of Bacfo Pharmaceuticals (India ) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Financials of Bacfo Pharmaceuticals (India ) Limited
FY 2025 filings availableBacfo Pharmaceuticals (India ) Limited reported revenue of ₹76.93 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹76.93 Cr ▲ 24%
Net profit · FY 2025
₹2.5 Cr margin 3.2%
EBITDA · FY 2025
₹8 Cr margin 10.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 23%
5 years · compounded
▲ 39%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 26%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 24% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.5 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.4% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Board of directors of Bacfo Pharmaceuticals (India ) Limited
Bacfo Pharmaceuticals (India ) has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Achal Kumar Chauhan Also directs: Cincorp International Limited, I Finance Company Limited, Atharv Care India Private Limited and 1 more | Director | 07 Mar 2013 | 13 Years 8 Months | Current |
| Rajesh Puri Also directs: Kunstocom (India) Limited | Director | 01 Jul 2006 | 20 Years 4 Months | Current |
| Arun Chauhan Also directs: Cincorp International Limited, Technicom Chemie (India) Limited, Bacfo & Krauter Holdings Private Limited and 4 more | Managing Director | 21 Oct 1994 | 32 Years 0 Months | Current |
| Akhil Chauhan Also directs: Cincorp International Limited, I Finance Company Limited, Atharv Care India Private Limited and 1 more | Director | 28 Dec 2006 | 19 Years 10 Months | Current |
Peer comparison
Bacfo Pharmaceuticals (India ) Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adroit Pharmaceuticals Private Limited | ₹80.51 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Bacfo Pharmaceuticals (India ) Limitedthis company | ₹76.93 Cr (FY 2025) | ₹2.5 Cr | 3.2% | 24.0% | 224 | New Delhi, Delhi, India |
| Austro Labs Limited | ₹76.29 Cr (FY 2024) | -4.0% | Delhi, India | |||
| Bennet Pharmaceuticals Limited | ₹75.82 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Auditor
Bacfo Pharmaceuticals (India ) Limited is audited by Alok Mittal & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Alok Mittal & Associates | FY 2024 | 005717N |
Shareholding
The shareholding of Bacfo Pharmaceuticals (India ) Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Charges & borrowings
Open charges
₹27.1 Cr
Satisfied charges
₹8.61 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Nov 2022 | 100651541 | Axis Bank Limited | ₹3 Cr | Open | |
| 26 Aug 2022 | 100610832 | Hdfc Bank Limited | ₹33.49 Lakh | Open | |
| 30 Apr 2022 | 100574605 | Axis Bank Limited | ₹6 Cr | Open | |
| 17 Feb 2022 | 100552538 | Axis Bank Limited | ₹1.44 Cr | Open | |
| 13 Oct 2021 | 100492588 | Axis Bank Limited | ₹4 Cr | Open |
To see the full charge records of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Bacfo Pharmaceuticals (India ) Limited has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in March 2022.
Total deals
4
Secondary share transfers
2
Rights issue
1
Funding round
1
Disclosed funding
₹25.5 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹38.3 Lakh | Investors: 4 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Technicom Cheme (India) Limited |
| Mar 2014 | Funding round | ₹25.5 Lakh | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bacfo Pharmaceuticals (India ) Limited has 5 court cases on record: 5 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed against the company
5
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
| High courts | 1 | 1 | 1 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed against the company by Biostadt India Limited | Pending |
| District court, Thrissur, Kerala | Criminal case | Filed against the company by an individual | Pending |
| District court, Thrissur, Kerala | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| District court, East Godavari, Andhra Pradesh | Criminal complaint | Filed against the company by The State of Andhra Pradesh,Rep by Drugs Inspector | Disposed |
To see the full case history of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bacfo Pharmaceuticals (India ) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Bacfo Pharmaceuticals (India ) has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Bacfo Pharmaceuticals (India ) Limited has a workforce of 224 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
224
Active EPFO establishments
1
Employee growth
16.1%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 224 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
GST
Bacfo Pharmaceuticals (India ) has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCB0033E1ZD | Uttar Pradesh | Active | 01 Jul 2017 |
| 03AABCB0033E1ZP | Punjab | Active | 20 Apr 2023 |
To see the full GST registrations and return filing status of Bacfo Pharmaceuticals (India ) Limited, buy the company report.
Recent activity
Bacfo Pharmaceuticals (India ) Limited has 7 board changes on record since 1994: 4 appointments and 3 cessations. The latest: Achal Kumar Chauhan ceased to be Additional Director on 29 Sep 2025.
AGM
Bacfo Pharmaceuticals (India ) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Achal Kumar Chauhan ceased to be Additional Director.
Filing
Bacfo Pharmaceuticals (India ) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Axis Bank Limited of Rs. 8.18 Cr registered on 31 Jan 2020 with Charge ID 100323373 was modified on 10 Sep 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 3.00 Cr with Charge ID 100651541 was registered on 21 Nov 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.33 Cr with Charge ID 100610832 was registered on 26 Aug 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 6.00 Cr with Charge ID 100574605 was registered on 30 Apr 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.44 Cr with Charge ID 100552538 was registered on 17 Feb 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.00 Cr with Charge ID 100492588 was registered on 13 Oct 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.15 Cr with Charge ID 100339090 was registered on 11 May 2020.
Charges
A charge registered on 18 Dec 2019 via Charge ID 100310045 with Others was fully satisfied on 13 Feb 2020.
Charges
A charge registered on 21 Oct 2015 via Charge ID 10602493 with Kotak Mahindra Bank Limited was fully satisfied on 13 Feb 2020.
17 earlier events are in the company report.
Frequently asked questions
Bacfo Pharmaceuticals (India ) is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 October 1994 (32+ years old) and is registered under CIN U74899DL1994PLC062272.
Bacfo Pharmaceuticals (India ) has 4 current directors:
- Arun Chauhan - Managing Director
- Achal Kumar Chauhan - Director
- Rajesh Puri - Director
- Akhil Chauhan - Director
The latest financial statements of Bacfo Pharmaceuticals (India ) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bacfo Pharmaceuticals (India ) is 09AABCB0033E1ZD, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 03AABCB0033E1ZP (Punjab).
The CIN (Corporate Identification Number) of Bacfo Pharmaceuticals (India ) is U74899DL1994PLC062272. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bacfo Pharmaceuticals (India ) has 5 court cases on record: 5 filed against it. 2 are pending. Most are in the district courts.
Bacfo Pharmaceuticals (India ) was incorporated on 20 October 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Bacfo Pharmaceuticals (India ) has 4 deals on record (2 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹25.5 Lakh; the latest was in March 2022.
The peers of Bacfo Pharmaceuticals (India ) by revenue are Adroit Pharmaceuticals Private Limited, Austro Labs Limited, Bennet Pharmaceuticals Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Achal Kumar Chauhan ceased to be Additional Director on 29 Sep 2025. Abhishek Chauhan ceased to be Additional Director on 03 Nov 2014. Achal Kumar Chauhan was appointed as Director on 07 Mar 2013. Bacfo Pharmaceuticals (India ) has 7 board changes on record in total.
Yes, Bacfo Pharmaceuticals (India ) is registered as a small enterprise under Udyam registration (number: UDYAM-UP-28-0011963).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages